This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

    More

    Page   1/4   
  • Transformation beyond reform
    Explore key topics from the Financial Times U.S. Healthcare and Life Sciences Conference, held 6 June 2013.
  • Health care reform and life sciences: Threat, opportunity or both?
    Changing innovation processes and sales models crucial for companies to get ahead
  • Deloitte ranked #1 worldwide, based on revenue, in Life Sciences Consulting by Kennedy
    Deloitte provides one of the widest ranges of capability in the industry, says report.
  • Meet Phil Pfrang
  • Deloitte 2013 global life sciences outlook: Industry adopting new business model to address changing landscape, declining profit
    The DTTL report, 2013 global life sciences outlook: Optimism tempered by reality in a “new normal”, concludes that there are several drivers, such as patent expirations, regulatory scrutiny and shifts in innovations are prompting change in the industry.
  • 2013 Global life sciences outlook
    Report examines current global life sciences industry trends and issues, reviews activity in varying geographic markets, and suggests considerations for companies as they seek to grow revenue and market share.
  • Focus: FT Global Pharma & Biotech Conference 2012
    Life sciences & health care collection spotlights Deloitte reports and involvement at Financial Times Global Pharmaceutical and Biotechnology Conference 2012.
  • Deloitte survey: Challenges abound, yet LSHC industry comes to terms with transparency in healthcare payments
    Physicians favor a publicly available, searchable database of all physician-industry relationships.
  • Physician Payment Sunshine Act
    How are physicians and life sciences companies coming to terms with transparency?
  • Managing the uncertainty of reform
    What lies ahead for life sciences and health care after U.S. health care reform? Learn about the Financial Times U.S. Healthcare and Life Sciences Conference, 6 June 2012.
    • Page   1/4   
Material on this website is © 2013 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/kr/en/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Get connected
Share your comments

 

More on Deloitte
Learn about our site

 


Stay connected
  • Facebook RSS